
CVS Health Tops Estimates at $108.4 Billion Revenue and Raises 2026 Guidance
The company now expects full-year adjusted EPS of at least $8.20, up from a prior range of $7.90 to $8.10.
CVS HEALTH Corp · NYSE · Retail-Drug Stores and Proprietary Stores

The company now expects full-year adjusted EPS of at least $8.20, up from a prior range of $7.90 to $8.10.
No open-market insider buying or selling in the Form 4s filed since July 24, 2026.
Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedCVS Health Announces Plan to Separate Into Two Companies, Expects Completion in First Half of 2028, and Raises 2026 Guidance
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedCVS Health Q3 2026 adjusted EPS of $2.09 beats $1.65 consensus; full-year adjusted EPS guidance raised to at least $8.20 from $7.90-$8.10
Departure/appointment of directors or officers · Regulation FD disclosure · Financial statements and exhibits
Results of operations and financial condition · Financial statements and exhibits